Tag: manufacturing defects

Investigating Residual Solvent OOS in Transdermal Patch Manufacturing: Ensuring Compliance and Quality In the pharmaceutical manufacturing landscape, unexpected out-of-specification (OOS) results can critically undermine product integrity and regulatory compliance. One…

Investigation of Edge Lifting Observed During Stability Pull in Transdermal Patches In the pharmaceutical manufacturing sector, ensuring the quality and integrity of products is paramount. A recent incident involving edge…

Understanding and Investigating Edge Lifting Observed During Storage Edge lifting is a critical defect identified in transdermal patch storage, representing a significant risk for pharmaceutical manufacturers. Recognizing this issue early…

Backing Delamination Issues Following Adhesive Modifications – An Investigation Guide In the pharmaceutical manufacturing landscape, ensuring product integrity and performance is paramount. One recurring issue among transdermal patches is the…

Addressing Edge Lifting Issues in Transdermal Patch Production Edge lifting is a notable defect observed in transdermal patches, particularly after the lamination process. This defect can pose significant risks during…

Investigation of Patch Curling After Lamination: Robust CAPA Documentation Strategies Manufacturing defects in transdermal patches, particularly issues such as patch curling after lamination, can pose serious challenges in pharmaceutical quality…

Addressing Dose Delivery Inconsistencies Found During Storage: A Comprehensive Investigation In the pharmaceutical manufacturing realm, consistency in dose delivery is paramount, particularly for complex products such as transdermal patches. A…

Investigation of Edge Lifting During Lamination: Identifying Root Causes in Transdermal Patch Manufacturing Manufacturing defects, particularly edge lifting observed after lamination in transdermal patches, can have significant implications for product…

Unraveling Residual Solvent OOS Issues Post Adhesive Change Residual solvent out-of-specification (OOS) results pose significant challenges in pharmaceutical manufacturing, particularly after changes in critical components like adhesives. Understanding the root…

Coating Weight Variability in Stability Pulls: An Effective Investigation Framework In pharmaceutical manufacturing, particularly in the production of transdermal patches, coating weight variability during stability pulls can pose serious compliance…

Analyzing Coating Weight Variability in Transdermal Patch Manufacturing: A Root Cause Investigation The pharmaceutical industry constantly faces challenges associated with producing consistent product quality, particularly in complex manufacturing processes like…

Understanding and Addressing Backing Delamination in Transdermal Patch Manufacturing Backing delamination is a critical concern in the manufacturing of transdermal patches, which could compromise product performance and patient safety. In…